Articles

A Guggenheim analyst still sees a “mountain of challenges” but says Snowflake’s full-year forecast looks beatable.

The New York Fed’s Empire State business-conditions index, a gauge of manufacturing activity in the state, fell 18.5 points in March to negative 20.9, the regional bank said Friday.

The cost of imported goods rose in February for the second month in a row and added to a small upturn in U.S. inflation early in the new year.

One central bank head reportedly quoted the Italian philosopher Antonio Gramsci about the dollar’s dominance on the world stage: “The old world is dying, and the new world struggles to be born: now is the time of monsters.”

Jabil called out “revenue headwinds” as it posted slightly disappointing top-line results for its latest quarter and issued a downbeat outlook.

Spouses often have different expectations that can be harmonized

BlackRock is rolling out two new exchange-traded funds that use option strategies, a hot area of the ETF market in the U.S.

Bristol Myers Squibb’s cell therapy Breyanzi won FDA approval Thursday for treatment of a common type of leukemia.

Hibbett’s stock fell premarket Friday after the company, which is working with Nike, missed earnings expectations in its latest quarter.

Jon Gray said interest rate cuts are set to lift real estate prices, creating opportunities for investors

Piper Sandler upgraded Rivian shares to a bullish rating, calling the company’s new lineup “just so cool.”

Bitcoin slumped on Friday, with the cryptocurrency extending its decline from the record high reached this week.